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Abstract
The microvasculature of the corpus luteum (CL), which comprises greater than 50% of the total
number of cells in the CL, is thought to be the first structure to undergo degeneration via apoptosis
during luteolysis. These studies compared the apoptotic potential of various cytokines (tumor
necrosis factor α, TNFα; interferon gamma, IFNγ; soluble Fas ligand, sFasL), a FAS activating
antibody (FasAb), and the luteolytic hormone prostaglandin F2α (PGF2α) on CL-derived endothelial
(CLENDO) cells. Neither sFasL, FasAb nor PGF2α had any effect on CLENDO cell viability. Utilizing
morphological and biochemical parameters it was evident that TNFα and IFNγ initiated apoptosis
in long-term cultures. However, TNFα was the most potent stimulus for CLENDO cell apoptosis
at early time points. Unlike many other studies described in non-reproductive cell types, TNFα
induced apoptosis of CLENDO cells occurs in the absence of inhibitors of protein synthesis. TNFα-
induced death is typically associated with acute activation of distinct intracellular signaling pathways
(e.g. MAPK and sphingomyelin pathways). Treatment with TNFα for 5–30 min activated MAPKs
(ERK, p38, and JNK), and increased ceramide accumulation. Ceramide, a product of sphingomyelin
hydrolysis, can serve as an upstream activator of members of the MAPK family independently in
numerous cell types, and is a well-established pro-apoptotic second messenger. Like TNFα,
treatment of CLENDO cells with exogenous ceramide significantly induced endothelial apoptosis.
Ceramide also activated the JNK pathway, but had no effect on ERK and p38 MAPKs. Pretreatment
of CLENDO cells with glutathione (GSH), an intracellular reducing agent and known inhibitor of
reactive oxygen species (ROS) or TNFα-induced apoptosis, significantly attenuated TNFα-induced
apoptosis. It is hypothesized that TNFα kills CLENDO cells through elevation of reactive oxygen
species, and intracellular signals that promote apoptosis.
Background
Progesterone derived from the corpus luteum (CL) is re-
quired for the establishment and maintenance of a suita-
ble uterine environment during early pregnancy [1,2].
Inappropriate luteal function (i.e.  luteal insufficiency)
may contribute to the high incidence of spontaneous
abortions that occur early in mammalian pregnancies [3].
In most species, the luteolytic cascade, starting with loss of
progesterone production and followed by tissue regres-
sion (i.e.  apoptosis), is initiated by prostaglandin F2α
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(PGF2α) in vivo [4]. However, this process can only be par-
tially recapitulated in vitro using primary cultures of ster-
oidogenic cells. Gonadotropin-induced progesterone
production is attenuated by PGF2α treatment, but this
prostanoid does not activate apoptosis of bovine ster-
oidogenic cells in vitro [8]. These findings helped develop
the concept that additional factors, such as immune cells
[5–7] or cytokines [7,8], contribute to the luteolytic proc-
ess. Indeed, tumor necrosis factor α (TNFα), interferon
gamma (IFNγ) and/or interleukin-1 beta (IL-1β) have all
been shown to reduce gonadotrophin-induced progester-
one synthesis in a number of species [8–12], and TNFα
and IFNγ are known to increase PGF2α production by ster-
oidogenic cells [13–15]. Steroidogenic cell apoptotic par-
adigms are activated by cytokines generated by several cell
types within the CL, including immune cells and endothe-
lial cells [7,11,16]. The synergistic actions of IFNγ and TN-
Fα, for example, induce steroidogenic cell apoptosis
[13,17], as does soluble Fas ligand (FasL) [18–26]. Fur-
thermore, several acute intracellular signaling events ei-
ther required for, or associated with, the functional and
structural aspects of luteal regression have been mapped
using in vitro steroidogenic cell cultures [8,27,28].
The microvasculature of the CL is thought to be the first
structure to undergo degeneration via apoptosis during
luteolysis [2,8]. In contrast to information available on
steroidogenic cells of the CL, a gap exists in our under-
standing of the factors and their associated signaling path-
ways that initiate apoptosis in the vascular component of
the CL. Elevated TNFα activity may play a role in the ap-
optosis of CL-derived microvascular endothelial (CLEN-
DO) cells [29]. TNFα is known to initiate apoptosis in
diverse cell types by activating its cognate receptor, TNF-
RI, a cell surface receptor and member of the tumor necro-
sis receptor super family (TNFRSF). TNF-RI is also a death
receptor based on the presence of a carboxy-terminal
functional domain known as the death domain. The
death domain serves as a binding domain for cytoplasmic
adapter  proteins, which contain a death domain and a
death effector domain (i.e. Fas associated death domain,
FADD)[30] ultimately activating members of the caspase
family resulting in apoptosis. Activation of TNFRI initiates
stress-activated pathways, which often are associated with
the onset of apoptosis in a cell specific fashion.
Of interest to these studies are the three subfamilies with-
in the mitogen-activated protein kinase (MAPK) super-
family including the extracellular signal-related kinases
(ERKs), p38 and c-jun N-terminal kinases (JNKs) [31].
TNFα is one of many cytokines involved in luteal regres-
sion. Although the mechanism(s) by which cytokines in-
duce apoptosis vary among cell types, it is presumed that
it involves either an increase in reactive oxygen species
(ROS) or activation of stress-related signaling pathways.
Interestingly it has been demonstrated that rapid produc-
tion of ROS in endothelial cells exposed to TNFα is medi-
ated by ceramide [32]. Ceramide is a central figure in the
sphingomyelin pathway, which has also been linked to
stress related signaling and apoptosis [33,34]. This report
provides evidence that cytokines regulate the fate of
CLENDO cells. In the first set of experiments, we identi-
fied those factors that initiate CLENDO cell death
amongst a host of cytokines and lipid signaling molecules
that mediate various aspects of luteal structural regression.
In a second series of experiments, we evaluated the activa-
tion of several signal transduction pathways known to co-
ordinate apoptosis in other cell types. A working
knowledge of the collective signaling network activated in
CLENDO cells by specific death stimuli is essential to
complete our understanding of how apoptosis is control-
led within the CL.
Materials and Methods
Cell culture and treatments
Purified bovine CL-derived microvascular endothelial cell
populations were generated commercially by Cambrex Bi-
osciences (BioWhittaker, Walkersville, MD) as described
in detail [35]. In the present study, CLENDO cells from
frozen aliquots (passage 3) were seeded (5,000 cells/cm2)
in 6- or 24-well plates or 10 cm culture dishes. The cells
were cultured in EGM-2MV, as recommended by the sup-
plier with progesterone (250 ng/ml) and 3% fetal bovine
serum added. Once 90% confluency was reached, the me-
dium was changed and the cultures were maintained in
serum- and growth factor-free conditions (EBM-2 medi-
um) for 24 h. Medium was then removed once again and
fresh serum- and growth factor-free medium was applied.
Cells were allowed to equilibrate for a minimum of 3 h
prior to treatment. Treatment concentrations were based
upon previously published in vitro studies of mixed luteal
cells [13–15,17,29,36] and all experiments were complet-
ed a minimum of three times.
To identify putative luteolytic factors that initiate CLEN-
DO cell apoptosis, cells were treated with TNFα (50 ng/
ml; Upstate Biotechnology, Inc.; Lake Placid, NY), bovine
IFNγ (200 IU/ml; generous gift from Dr. Dale Godson,
Veterinary Infectious Disease Organization, University of
Saskatchewan, Saskatoon, Saskatchewan, Canada), sFasL
(50 ng/ml; Oncogene, LaJolla, CA), mouse Fas activating
antibody (Jo2; 500 ng/ml; Pharmingen, San Diego, CA),
human Fas activating antibody (CH-11; 500 ng/ml; Up-
state Biotechnology, Inc., Lake Placid, NY), PGF2α (1 µM;
Sigma Chemical Company; St. Louis, MO) or C2 cera-
mide (50 µM; BioMol; Plymouth Meeting, PA) for 24, 48
and 72 h. To confirm specificity of ceramide in triggering
CLENDO cell death, cultures were treated with sphingo-
sine-1-phosphate (S1P; 10 or 50 µM; BioMol; Plymouth
Meeting, PA) for 48 h. Furthermore, to determine if S1PReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/17
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attenuated ceramide- or TNFα-induced cell death, CLEN-
DO cells were first pretreated with S1P for 30 min, fol-
lowed by application of ceramide (50 µM) or TNFα (50
ng/ml). Finally, to evaluate the impact of glutathione
(GSH), a known inhibitor of TNFα-induced ROS forma-
tion and apoptosis, on CLENDO cell survival, cells were
pretreated with control media or GSH (10 mM) for 30
min, and then treated with or without TNFα (50 ng/ml)
for 48 h.
For Western blot analysis, CLENDO cells were treated
with TNFα (50 ng/ml) or C2 ceramide for 0, 2, 5, 10, 30,
or 60 min. Cell lysates were collected and assayed for ac-
tive MAPK family members as described below. For meas-
urements of ceramide content in response to TNFα (50
ng/ml) treatment, pre-equilibrated cells were treated with
TNFα (50 ng/ml) for 0, 2, 5, 10 or 30 min and lipids were
extracted as described below.
Parameters of apoptosis
To identify apoptosis-inducing agents in CLENDO cells,
culture medium was removed following treatments, cells
were washed one time with ice cold PBS, and fixed for 10
min with 4% paraformaldehyde. The cells were rinsed one
time with PBS and nuclei stained by placing 200 µl glycer-
ol (80% in 1X PBS) containing 2 µg/ml Hoechst 33258 in
each well. While pyknotic nuclei were visible in adherent
cells in response to some treatments, we also observed a
large number of dead, floating cells as confirmed by
trypan blue staining. Thus, the average number of non-ap-
optotic cells in 10 fields was determined and presented as
raw values. Biochemical analyses were employed to verify
whether or not cell loss was the result of apoptosis.
Oligonucleosomal DNA fragmentation was used as a bio-
chemical marker of endothelial cell apoptosis in which
cells were untreated for 48 h, treated with TNFα (50 ng/
ml) for 12, 24 or 48, or treated with C2 ceramide (50 µM)
for 12 h. Cells were scraped and separated from culture
medium by centrifugation (1200 rpm, 10 min, 4°C) and
DNA was isolated as described [37]. Following electro-
phoresis, fragmented DNA (5 µg) was visualized by ethid-
ium bromide staining. To provide a second source of
biochemical evidence that TNFα induced apoptosis, con-
fluent cultures of CLENDO cells were incubated with a
fluorogenic substrate, which detects caspase-3 activity (10
µM, DEVD sequence; Phi Phi Lux; OncoImmunin, Inc,
College Park, MD) at 2 and 8 h after TNFα treatment for
30 min. These times were selected since no visible mor-
phological signs (chromatin condensation or formation
of apoptotic bodies) of apoptosis were evident until after
12 h. Following the incubation, cells were rinsed 3 times
with medium and analyzed by fluorescent microscopy as
described [26,38].
Western blot analysis
Protein lysates were collected for Western blot analysis as
described elsewhere [17,35,39]. Briefly, following separa-
tion by SDS-PAGE, the proteins (20 µg/lane) were trans-
ferred (100 V, 1 h) to polyvinylidene difluoride
membranes. Nonspecific binding was blocked with 5%
fat free milk in TBST [50 mM Tris-HCL (pH7.5) 0.15 Na-
Cl, 0.05% Tween-20] 1 h at room temperature. Mem-
branes were then incubated with primary antibodies to
various MAPK family members overnight at 4°C (phos-
pho-ERK, 1:5000, Promega; Madison, WI; phospho-p38,
1:1000, New England Biolabs, Beverly, MA; phospho-
JNK, 1:500, Santa Cruz Biotechnology, Inc., Santa Cruz,
CA). Previous studies have demonstrated that these anti-
bodies recognize the phosphorylated (active) forms of ex-
tracellular-regulated kinase (ERK), p38, and Jun-N-
terminal kinase (JNK) Membranes were then washed (3 ×
5 min each) with TBST buffer and incubated with anti-
rabbit IgG horseradish peroxidase conjugate or anti-
mouse IgG horseradish peroxidase conjugate (1:2000;
Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h at
room temperature. The membranes were washed with
TBST as before and the bound antibody was detected us-
ing ECL reagents based on the manufacturer's recommen-
dations (Amersham; Piscataway, NJ). X-ray films were
scanned and band intensity was determined using a Ko-
dak-1D software package. Since pJNK, pERK and panERK
appear in two isoforms, both bands were scanned togeth-
er. To verify equal protein loading membranes were then
stripped and re-probed with the panERK antibody
(1:1000; Transduction Laboratories; Lexington, KY)
which recognizes the constitutively expressed ERKs in bo-
vine CLENDO cells as previously described [35].
Evaluation of ceramide production in response to TNFα
The amount of ceramide generated by CLENDO cells in
response to TNFα treatment (50 ng/ml) was determined
in three independent sets of experiments via the diacyl
glycerol kinase assay as described [26,40]. Each experi-
ment contained an untreated control that was used for
comparison with TNFα treated samples. Briefly, mem-
brane lipids were extracted (1 ml methanol, 10 min at -
80°C) from endothelial cells immediately following treat-
ment and dried under nitrogen gas. Lipids were subjected
to mild alkaline hydrolysis and dried under nitrogen gas.
Ceramide in the lipid extracts were labeled with [32P-ATP]
and the resulting products resolved using thin layer chro-
matography. Graded levels of commercially purified cera-
mides were employed as a standard curve. The band in
each lane corresponding to ceramide-1-phosphate was cut
from the chromatography plate and counted in a scintilla-
tion counter. Changes in ceramide production in response
to TNFα treatment were presented as a percentage of the
untreated control value.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/17
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Statistics
Assignment to treatments was made at random. Raw data
were subjected to least squares analysis of variance fol-
lowed by Duncan's new multiple range test or the Student
t-tests for paired comparisons. The results were expressed
as the mean ± SEM and a value of P < 0.05 was considered
significant.
Results
TNFα reduces viability of CLENDO cells
To determine which cytokines initiate apoptosis in CLEN-
DO cells we treated the cells for 48 h with TNFα, IFNγ, or
the combination of the two. TNFα treatment resulted in a
significant reduction in CLENDO cell viability (34 %, P <
0.05), which was reduced (P < 0.05) an additional 23 %
by co-treatment with IFNγ (Fig. 1a). Treatment with IFNγ
alone showed no statistical difference in viability com-
pared with the untreated control during the first 48 h of
treatment. Although Fas activating antibody, Jo2, induces
apoptosis in ovarian surface epithelial cells [23], Jo2 had
no effect on CLENDO cell survival. Similarly, treatment of
CLENDO cells with the luteolytic agent, PGF2α, for 48 h
failed to induce apoptosis compared to the untreated
control.
In a second group of experiments, we observed that
CLENDO cells were resistant to apoptosis when treated
for 72 h with sFasL or the human Fas activating antibody
Figure 1
TNFα induces loss of viability of CLENDO cells in vitro. (Panel A) CLENDO cells were treated for 48 h with media alone (Ctl), 
TNFα (50 ng/ml), IFNγ (200 IU/ml), Jo2 (500 ng/ml), or PGF2α (1 µM). Cells were stained with Hoechst 33258 and the num-
bers of non-apoptotic cells per field in each of 10 separate fields per dish were counted. (Panel B) CLENDO cells were treated 
for 72 h with media alone (control), soluble FasL (50 ng/ml), human Fas activating antibody (CH-11, 500 ng/ml) or bovine IFNγ 
(200 IU/ml). Cell viability was determined as described above. These data represent the mean ± SEM of at least three inde-
pendent experiments. The ''*'' denotes significance (P < 0.05) compared to untreated control.
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CH-11. Interestingly, treatment with IFNγ for 72 h
showed a modest increase (P < 0.05) in cell death com-
pared to the untreated control group (Fig 1b).
Treatment with TNFα caused a linear decrease in the
number of non-apoptotic CLENDO cells starting at 24 h
and continuing through 72 h of treatment (Fig. 2a).
CLENDO cells treated with TNFα for 12 h showed no sig-
nificant difference in the number of non-apoptotic cells
compared with the 72 h untreated control. However,
some cells in the 12 h group showed early signs of apop-
tosis in that pyknosis and partitioning of nuclei were ob-
served (not shown). To provide biochemical evidence that
the form of cell death observed was apoptosis, assays for
oligonucleosomal DNA fragmentation and caspase-3 ac-
tivity were performed. Oligonucleosomal DNA fragmen-
tation was evident 12 h after TNFα treatment and
continued through 24 and 48 h (Fig. 2b). Caspase-3 activ-
ity (cleavage of Phi Phi Lux) was easily detected by 8 h af-
ter TNFα treatment, and was evident as early as 2 h (Fig
2c.).
Ceramide is generated in response to TNFα treatment and 
kills CLENDO cells
Previous studies have shown that TNFα, like other death
receptors, stimulates the accumulation of the second mes-
senger ceramide, and that this lipid signaling molecule
can serve as an upstream activator of cell stress signaling
pathways [41]. Measurements of total cellular ceramide in
CLENDO cells revealed that ceramide levels were signifi-
cantly elevated (P < 0.05) as early as 2 min following
TNFα treatment, and remained elevated through 30 min
of treatment (Fig. 3a.). Treatment of CLENDO cells with
an exogenous source of ceramide (C2, 50 µM) caused a
significant decrease in cell viability starting 24 h after
treatment compared to untreated cells cultured for 72 h
(Fig. 3b). Treatment of CLENDO cells for 48 h with S1P at
either 10 µM or 50 µM concentrations did not induce
CLENDO cell death (data not shown). Furthermore, pre-
treatment of CLENDO cells for 30 min with S1P did not
prevent ceramide- or TNFα-induced apoptosis (data not
shown). As with TNFα treatment, application of ceramide
to CLENDO cells resulted in oligonucleosomal DNA frag-
mentation within 12 h, thus confirming apoptosis as the
mechanism of cell death (see Fig. 2b, lane 6).
Acute activation of the mitogen-activated protein kinase 
superfamily by TNFα and ceramide
Substantial data support the notion that ceramide serves
as an upstream signaling molecule in the activation of
other signaling pathways such as the mitogen-activated
protein kinase (MAPK) superfamily [33]. In the present
study quantitative measures were performed on members
of the MAPK superfamily using antibodies that recognize
only the phosphorylated, and presumptively active, forms
of ERK, JNK, and p38. Western blot analysis confirmed
that all three members of the MAPK superfamily were
transiently activated by treatment with TNFα (Fig. 4a).
The levels of phospho-ERKs increased within 5 min of
TNFα treatment, peaked by 10 min and decreased by 30
min (Fig. 4b). Phospho-p38 levels peaked at 5 min and
showed an equally rapid decline in activity. Levels of
phospho-JNK activity increased (P < 0.05) by 10 min and
remained elevated throughout 30 min of incubation with
TNFα (Fig. 4b).
Since ceramide is linked to MAPK signaling pathways [33]
we determined the effect of treatment of CLENDO cells
with an exogenous source of ceramide. Treatment with 50
µM C2 ceramide failed to activate the ERK and p38 MAPK
pathways. However, treatment with C2 ceramide did acti-
vate the JNK pathway similar to that observed with TNFα
treatment (Fig. 4c). Phospho-JNK was elevated with in 5
minutes after C2 addition and remained elevated for at
least 30 min.
Glutathione attenuates TNFα-induced cell death
Since TNFRSF induces cell death by causing an efflux of
glutathione (GSH) in other cell types [42] we sought to
determine if pretreatment of CLENDO cells with GSH
would attenuate lethality associated with TNFα treatment.
CLENDO cells pretreated for 30 min with GSH were sig-
nificantly less susceptible (P < 0.05) to the lethal effects of
TNFα over a 48 h period than cells treated with TNFα
alone (Fig. 5). Treatment with GSH alone had no effect on
the CLENDO cell viability.
Discussion
Treatment of animals with PGF2α or its analogs results in
endothelial cell death in vivo [43], suggesting that PGF2α
may have a direct effect on CLENDO cells. However, the
microvasculature of the CL is composed of a number of
different luteal endothelial cell types; the most common
of which does not express mRNA encoding the PGF2α re-
ceptor FP [35,44]. This particular endothelial cell type is
unresponsive to PGF2α treatment [35] in that PGF2α treat-
ment does not increase the secretion of monocyte chem-
oattractant protein-1 [35] or stimulate well-recognized
PGF2α-responsive intracellular signaling pathways
[35,36]. Lehmann, et al. [45] recently characterized a pre-
dominant cytokeratin-negative endothelial cell type in the
bovine CL in addition to a "rare" cytokeratin-positive en-
dothelial cell type. These two cell populations may have
different functional capacities in that they differ in their
expression of FP [44,45], as well as their secreted cytokine
profiles [45]. In the present studies PGF2α was incapable
of directly inducing apoptosis of CLENDO cells. Conse-
quently, there is some question as to whether PGF2α has
any direct effect on CLENDO cell function, which directedReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/17
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Figure 2
Apoptosis is the form of luteal microvascular endothelial cell death initiated by TNFα. (Panel A) Cells were treated TNFα (50 
ng/ml) for 72 h and cell viability determined after Hoechst staining. The numbers of non-apoptotic cells per field in each of 10 
separate fields of view per dish were counted. These data represent the mean ± SEM of at least three independent experi-
ments. The ''*'' denotes significance (P < 0.05) compared to untreated control. (Panel B) Oligonucleosomal DNA fragmentation 
of CLENDO cells cultured for 48 h in serum and growth factor free conditions (control, lane 2); or for 12 h (lane 3), 24 h (lane 
4), or 48 h (lane 5) with TNFα (50 ng/ml), and for 48 h with ceramide (50 µM, lane 6). Lane 1 shows a low molecular weight 
DNA ladder. (Panel C) Cleavage of Phi Phi Lux, demonstrating caspase-3 activity in CLENDO cells treated with TNFα (50 ng/
ml) for 2 or 8 h.
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our attention toward other known luteolytic factors (i.e.,
cytokines).
A primary objective of this study was to determine which
cytokines initiate CLENDO cell death. Of the various cy-
tokines tested (TNFα, IFNγ, or sFasL), TNFα was the only
potent initiator of CLENDO cell death. Time course anal-
ysis suggested that the loss of viability was rapid (Fig 1a
and 2a) and progressive, with only 30 % of the cells re-
maining non-apoptotic by 72 hr post-treatment. The
rapid induction of apoptosis in response to TNFα is simi-
lar to the microvascular endothelial cell death which was
observed by Friedman and colleagues [29] at higher con-
centrations of TNFα. One receptor for TNFα, TNF-RI is ex-
pressed throughout the bovine estrous cycle [46], but is
more abundantly expressed by the endothelial cell com-
ponent than in steroidogenic cells [29].
At physiological concentrations, TNFα induces cell death
in most TNFα responsive cell types via apoptosis. This ef-
fect was evident in CLENDO cells by hallmark features of
apoptosis including nuclear chromatin condensation, for-
mation of apoptotic bodies and it was confirmed by an in-
crease in caspase-3 activity and oligonucleosomal DNA
fragmentation. Active caspase-3 is a functional require-
ment of spontaneous luteal regression in that caspase-3-
deficient mice retain CL for a longer period of time than
wild type littermates [47]. However, this murine study did
Figure 3
TNFα activates the sphingomyelin signaling pathway in CLENDO cells. (Panel A) CLENDO cells were treated for up to 30 min 
with TNFα (50 ng/ml) and ceramide levels were determined as described in the Materials and Methods. (Panel B) The numbers 
of non-apoptotic cells per field in each of 10 separate fields per dish were counted in which cultures of CLENDO cells were 
treated with exogenous ceramide (C2, 50 µM) for up to 72 h under serum- and growth factor-free conditions. Ctl, untreated 
controls cultured in parallel for 72 h in serum free, growth factor free medium. * = P < 0.05. These data represent mean ± SEM 
of at least three independent experiments.
0
20
40
60
80
100
120
N
o
n
-
a
p
o
p
t
o
t
i
c
 
c
e
l
l
s
(
c
e
l
l
s
/
f
i
e
l
d
 
o
f
 
v
i
e
w
)
Ctl 12 h 24 h 48 h 72 h
C2 ceramide
*
* *
0
50
100
150
200
0           2              5             10           30
Time (minutes)
C
h
a
n
g
e
 
i
n
 
c
e
r
a
m
i
d
e
(
p
e
r
c
e
n
t
 
o
f
 
c
o
n
t
r
o
l
)
* *
* *Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/17
Page 8 of 11
(page number not for citation purposes)
Figure 4
TNFα and the TNFα-induced second messenger ceramide activate members of the MAPK superfamily. (Panel A) Western blot 
of lysates from CLENDO cells treated for up to 60 min with TNFα (50 ng/ml) probed with antibody to phosphorylated ERK, 
p38, JNK and pan-ERK. Pan-ERK antibody, which detects all activated and inactivated ERK isoforms was used for normalization. 
(Panel B) Graphical representation of the percent change in expression of MAPK superfamily after densitometry of band devel-
oped in Western blots analysis as in Panel A and normalization to panERK. These data represent mean ± SEM of at least three 
independent experiments. * = P < 0.05. (Panel C) Treatment with ceramide, a product of TNFα treatment in CLENDO cells, 
for up to 60 min and Western blot detection of phosphorylated JNK isoforms. This Western blot is representative of similar 
results obtained in at least three separate experiments.
0     2     5    10   30   60 min
C2 ceramide
pJNK
pan-ERK
0
100
200
300
400
0
100
200
300
400
0   2  5      10   30      60 min
pERK
pJNK
pp38
R
e
l
a
t
i
v
e
 
L
e
v
e
l
(
%
 
o
f
 
c
o
n
t
r
o
l
)
02 5 1 0 3 0 6 0  m i n
0
100
200
300
400
*
* **
panERK
pJNK
pp38
pERK
0     2       5     10      30     60 minReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/17
Page 9 of 11
(page number not for citation purposes)
not delineate which luteal cells were affected. Whether
caspase-3 activity is a required component of the luteal
endothelial cell apoptosis paradigm remains to be
determined.
Unlike TNFα, other cytokines (IFNγ or sFasL) or Fas acti-
vating antibodies had little effect on the endothelial cell
viability. It is not readily apparent why these cytokines
failed to induce CLENDO cell death, but one explanation
may be the lack of cognate receptors on the cell surface.
Co-treatment of luteal endothelial cells with IFNγ aug-
mented TNFα-induced death, a result that may be ex-
plained in two ways. First, it is possible that the signaling
events initiated by the combined treatment of TNFα and
IFNγ are more potent at activating endothelial cell death
than TNFα alone. Alternatively, IFNγ may increase the ex-
pression of the death domain containing TNF-RI and thus
increase the luteal endothelial cell death susceptibility
upon exposure to TNFα. This later suggestion has been
shown to be the case in luteal steroidogenic cells for an-
other death receptor, in which Fas mRNA expression in-
creased in response to IFNγ treatment [20,22].
Interestingly, we find that two different cytokines (i.e.
sFasL and TNFα) can activate the sphingomyelin pathway
in two distinct CL cell types. TNFα elevates ceramide in
CLENDO cells, whereas sFasL elevates ceramide in prima-
ry luteal steroidogenic cells [26]. Ceramide treatment in-
duces apoptosis in both cell types, suggesting that the
sphingomyelin pathway may be a common mediator of
cell death among distinct cell types within the CL.
Sphingomyelin content and luteal cell membrane fluidity
decrease during luteolysis in vivo [48–51]. Ceramide, a
product of sphingomyelin hydrolysis, is a potent stress-ac-
tivated second messenger and is well established as a func-
tional component of death receptor-mediated apoptosis
[52–54]. Upon treatment of CLENDO cells with TNFα, we
observed a rapid and sustained increase in the production
of ceramide, suggesting that the sphingomyelin pathway
is present and active in these cells. Exogenous ceramide in-
duced CLENDO cell oligonucleosomal DNA fragmenta-
tion and reduced cell viability in a manner consistent with
TNFα treatment. The exact role and functional signifi-
cance of ceramide production in response to TNFα in
CLENDO cell apoptosis are not presently known. Howev-
er, in some cell types, ceramide production has been
placed at the top of molecular ordering schemes for sever-
al signaling cascades as well as increase in reactive oxygen
species. Substantial evidence exists to suggest that stress-
induced apoptosis is mediated through activation of
MAPK signaling pathways in non-ovarian cell types.
While these pathways are activated in luteal steroidogenic
cells by diverse cell stressors, including cytokines [55], no
such detailed studies have been completed to date in the
endothelial cell component of the CL. In the present study
we provide evidence that TNFα and a by-product of TNFα
signaling, ceramide, both have the capacity to activate
members of the MAPK family. Activation of MAPK stress
pathways can alter cell viability through multiple mecha-
nisms. For example, TNFα can activate transcription fac-
tors that bind genomic DNA and initiate gene expression
of pro-apoptotic genes [56,57].
A number of studies provide evidence that the luteolytic
process may involve a rapid and sustained increase in ROS
[58,59]. Other studies demonstrate that luteal regression
is associated with a dramatic decrease in the mRNAs
encoding enzymes responsible for regulating the intracel-
lular redox state [60]. Death induced by TNFα is also re-
portedly mediated by an increase in ROS, an event
correlated with a marked decrease in the vital intracellular
ROS scavenger GSH. Activation of TNF-RI and other death
domain containing receptors of the TNF receptor
superfamily have been shown to cause an efflux of GSH,
which contributes to the apoptotic process [42,61]. Provi-
sion of GSH in the present study reduced the deleterious
effects of TNFα on CLENDO cells. We suggest that one
mechanism by which TNFα induces CLENDO cell death
is through the formation of ROS, a result that may stem
from depletion of GSH stores in CLENDO cells. Provision
Figure 5
Glutathione (GSH) blocks TNFα-induced CLENDO cell 
death. CLENDO cells were pretreated with or without the 
reactive oxygen species scavenger GSH (10 mM, 30 min) 
prior to incubation for 48 h in the presence and absence of 
TNFα (50 ng/ml). CLENDO cell apoptosis was determined 
as described in the Material and Methods. The data represent 
mean ± SEM of at least three independent experiments 
where ''*'' denotes P < 0.05 compared to untreated control 
(Ctl).
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of exogenous GSH may restore the redox state disrupted
by TNFα treatment. These findings lend support to the no-
tion that TNFα contributes to luteolysis by initiating for-
mation of endothelial cell-derived ROS.
In this study, we have corroborated findings of Friedman
et al [29] that TNFα is a potent apoptotic stimulus of pri-
mary luteal microvascular endothelial cells and extend
these findings by characterizing the activation of several
stress-activated signal transduction pathways in response
to TNFα treatment of cultured endothelial cells. Whether
these acute signaling events are linked to, and functionally
required for, down stream apoptotic mechanisms remain
to be determined. Furthermore, the possibility that altera-
tions in GSH metabolism or cellular flux, and thus the re-
dox state, within CLENDOs result from exposure to TNFα
needs to be tested. These experiments as well as future
studies designed to identify the enzymatic pathway(s) and
in which cellular compartment(s) ceramide is generated
in luteal microvascular endothelial cells in response to
TNFα treatment should help determine which, if any, of
the acutely activated signal transduction pathways con-
tribute to luteal endothelial cell apoptosis. In conclusion,
TNFα activates several stress-activated signaling pathways
that may facilitate GSH efflux, and thus increase ROS and
subsequent cell death.
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